CSNY is the following is not a federal law affecting health insurance , health benefits plans or hmos .
<h3>What is meant by Health insurance?</h3>
A corporation and a customer enter into a contract for health insurance. In exchange for the payment of a monthly premium, the corporation offers to cover all or part of the insured person's medical expenses. In exchange for a monthly premium payment, health insurance covers the majority of the insured person's medical, surgical, and preventative care costs.
In general, the insured has lesser out-of-pocket expenses the larger the monthly payment is.
There are deductibles and co-pays in almost all insurance plans, but these out-of-pocket costs are now limited by federal law.
To learn more about health insurance refer to:
brainly.com/question/1941778
#SPJ4
Great Britain, Spain, and New Zealand
The Scenario:
A nursing assistant has entered a scene where a blood spill has occurred. After ensuring the patient is safe, the nursing assistant dresses in personal protective equipment, and removes the visible blood with an absorbent material. The nursing assistant then throws the blood-soaked material into the trash can.
What the nursing assistant did wrong:
The nursing assistant did not call the lead nurse to report the incident prior to cleaning.
Answer:
rationalization
Explanation:
Rationalization .....try to justify your actions
Answer:
Okay
Explanation:
Human topoisomerase I plays an important role in removing positive DNA supercoils that accumulate ahead of replication forks. It also is the target for camptothecin-based anticancer drugs that act by increasing levels of topoisomerase I-mediated DNA scission. Evidence suggests that cleavage events most likely to generate permanent genomic damage are those that occur ahead of DNA tracking systems. Therefore, it is important to characterize the ability of topoisomerase I to cleave positively supercoiled DNA. Results confirm that the human enzyme maintains higher levels of cleavage with positively as opposed to negatively supercoiled substrates in the absence or presence of anticancer drugs. Enhanced drug efficacy on positively supercoiled DNA is due primarily to an increase in baseline levels of cleavage. Sites of topoisomerase I-mediated DNA cleavage do not appear to be affected by supercoil geometry. However, rates of ligation are slower with positively supercoiled substrates. Finally, intercalators enhance topoisomerase I-mediated cleavage of negatively supercoiled substrates but not positively supercoiled or linear DNA. We suggest that these compounds act by altering the perceived topological state of the double helix, making underwound DNA appear to be overwound to the enzyme, and propose that these compounds be referred to as ‘topological poisons of topoisomerase I’
